These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Standardization of the CFU-GM assay: Advantages of plating a fixed number of CD34+ cells in collagen gels. Dobo I; Pineau D; Robillard N; Geneviève F; Piard N; Zandecki M; Hermouet S J Hematother Stem Cell Res; 2003 Oct; 12(5):543-51. PubMed ID: 14594511 [TBL] [Abstract][Full Text] [Related]
3. Successful cryopreservation of purified autologous CD34+ cells: influence of freezing parameters on cell recovery and engraftment. Beaujean F; Bourhis JH; Bayle C; Jouault H; Divine M; Rieux C; Janvier M; Le Forestier C; Pico JL Bone Marrow Transplant; 1998 Dec; 22(11):1091-6. PubMed ID: 9877272 [TBL] [Abstract][Full Text] [Related]
4. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation. Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292 [TBL] [Abstract][Full Text] [Related]
5. Positive selection of CD34+ cells from cryopreserved peripheral blood stem cells after thawing: technical aspects and clinical use. Bohbot A; Lioure B; Faradji A; Schmitt M; Cuillerot JM; Laplace A; Oberling F Bone Marrow Transplant; 1996 Feb; 17(2):259-64. PubMed ID: 8640176 [TBL] [Abstract][Full Text] [Related]
6. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Yang H; Acker JP; Cabuhat M; Letcher B; Larratt L; McGann LE Bone Marrow Transplant; 2005 May; 35(9):881-7. PubMed ID: 15778729 [TBL] [Abstract][Full Text] [Related]
7. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients. Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell depletion and enrichment of CD34+ hematopoietic progenitor cells from human umbilical cord blood using soybean agglutinin and CD34 immunoselection. Nagler A; Peacock M; Tantoco M; Lamons D; Okarma TB; Okrongly DA Exp Hematol; 1994 Nov; 22(12):1134-40. PubMed ID: 7523166 [TBL] [Abstract][Full Text] [Related]
9. Direct volumetric flow cytometric quantitation of CD34+ stem and progenitor cells. Gutensohn K; Nikolitsis A; Gramatzki M; Spitzer D; Buwitt-Beckmann U; Humpe A Transfus Med; 2012 Jun; 22(3):205-10. PubMed ID: 22519551 [TBL] [Abstract][Full Text] [Related]
10. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677 [TBL] [Abstract][Full Text] [Related]
11. Quantification of CD34+ cells mobilized into the peripheral blood predicts the yield of the leukapheresis product and can replace progenitor assays. D'Hondt L; André M; Guillaume T; Feyens AM; Humblet Y; Doyen C; Bosly A; Dromelet A; Chatelain B; Symann M Cytokines Cell Mol Ther; 1997 Mar; 3(1):21-6. PubMed ID: 9287240 [TBL] [Abstract][Full Text] [Related]
12. Association of CFU-Mk with total colony-forming units in thawed cord blood units. Eskola M; Arvola A; Juutistenaho S; Aranko K; Kekomäki R Vox Sang; 2012 Nov; 103(4):331-6. PubMed ID: 22725627 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Schneider JG; Crown JP; Wasserheit C; Kritz A; Wong G; Reich L; Norton L; Moore MA Bone Marrow Transplant; 1994 Dec; 14(6):877-84. PubMed ID: 7536069 [TBL] [Abstract][Full Text] [Related]
14. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation. Novitzky N; Mohamed R Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962 [TBL] [Abstract][Full Text] [Related]
15. Effects of incubation temperature and time after thawing on viability assessment of peripheral hematopoietic progenitor cells cryopreserved for transplantation. Yang H; Acker JP; Cabuhat M; McGann LE Bone Marrow Transplant; 2003 Nov; 32(10):1021-6. PubMed ID: 14595390 [TBL] [Abstract][Full Text] [Related]
16. Cryopreservation of mobilized blood stem cells at a higher cell concentration without the use of a programmed freezer. Kawano Y; Lee CL; Watanabe T; Abe T; Suzuya H; Okamoto Y; Makimoto A; Nakagawa R; Watanabe H; Takaue Y Ann Hematol; 2004 Jan; 83(1):50-4. PubMed ID: 14615914 [TBL] [Abstract][Full Text] [Related]
18. Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation. Stewart FM; Kaiser DL; Ishitani KP; Pirsch GW; Niskanen E Exp Hematol; 1989 Oct; 17(9):974-80. PubMed ID: 2673831 [TBL] [Abstract][Full Text] [Related]
19. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking. Almici C; Carlo-Stella C; Mangoni L; Garau D; Cottafavi L; Ventura A; Armanetti M; Wagner JE; Rizzoli V Stem Cells; 1995 Sep; 13(5):533-40. PubMed ID: 8528103 [TBL] [Abstract][Full Text] [Related]
20. Autologous transplantation: the viable transplanted CD34+ cell dose measured post-thaw does not predict engraftment kinetics better than the total CD34+ cell dose measured pre-freeze in patients that receive more than 2x10(6) CD34+ cells/kg. Abrahamsen JF; Wentzel-Larsen T; Bruserud O Cytotherapy; 2004; 6(4):356-62. PubMed ID: 16146888 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]